Investor Relations

SEC Filings

Document Highlights
Other Filings
Filing Description Filing Type Filing Date Event Date Download
8-K 8-K 2/8/2017 2/8/2017
Abstract: On Feb. 8, registrant reported the schedule of its 2017 annual meeting of shareholders.
8-K 8-K/A 12/19/2016 12/19/2016
Abstract: Registrant filed an amendment to the Form 8-K filed Oct. 3 to filed exhibit 23.1.
8-K 8-K 12/5/2016 12/5/2016
Abstract: Registrant reported that on Nov. 29, it and Evolent Health LLC entered into a purchase agreement JP Morgan Securities LLC and Goldman Sachs & Co. issue and sell $110.0 million aggregate principal amount of its 2.00% convertible senior notes due 2021. The indenture, among other things, was included by exhibit.
8-K 8-K 11/30/2016 11/29/2016
Abstract: On Nov. 29, registrant announced the pricing of $110 million of 2.00% convertible senior notes due 2021.
8-K 8-K 11/29/2016 11/29/2016
Abstract: On Nov. 29, registrant announced that it intends to offer $110 million of convertible senior notes due 2021.
10-Q 10-Q 11/10/2016 9/30/2016
8-K 8-K 11/9/2016 11/9/2016
Abstract: On Nov. 9, registrant reported its net loss for the quarter ended Sept.
8-K 8-K 10/3/2016 10/3/2016
Abstract: On Oct. 3, registrant announced the completion of its acquisition of Valence Health Inc. The first amendment to agreement and plan of merger was included by exhibit.
8-K 8-K 9/22/2016 9/22/2016
Abstract: Registrant reported that on Sept. 22, the sale of the shares of the registrant’s class A common stock by the Advisory Board Co., among others, pursuant to the overallotment option closed. The opinion and consent of Cravath Swaine & Moore LLP were included by exhibit.
8-K 8-K 9/14/2016 9/14/2016
Abstract: Registrant reported that on Sept. 8, it and Evolent Health LLC entered into an underwriting agreement for the sale of 7.5 million shares of class A common stock of the registrant. The underwriting agreement and the opinion and consent of Cravath Swaine & Moore LLP were included by exhibit.
Prospectus 424B7 9/9/2016
Prospectus 424B7 9/6/2016
10-Q 10-Q 8/9/2016 6/30/2016
8-K 8-K 8/4/2016 8/4/2016
Abstract: On Aug. 4, registrant reported its net loss for the quarter ended June 30.
Registration Statement S-3 7/28/2016
Abstract: Registrant filed a registration statement for up to 44,028,589 shares of class A common stock in an offering valued at approximately $1.03 billion offered by selling shareholders.
8-K 8-K 7/14/2016 7/14/2016
Abstract: On July 13, registrant and Valence Health Inc. announced that they entered into a definitive agreement for the registrant to acquire the majority of Valence Health’s business for approximately $145 million. The agreement and plan of merger was included by exhibit.
8-K 8-K 6/15/2016 6/15/2016
Abstract: Registrant reported the results of its annual meeting of stockholders held June 14. The second amended and restated certificate of incorporation was included by exhibit.
10-Q 10-Q 5/16/2016 3/31/2016
8-K 8-K 5/12/2016 5/12/2016
Abstract: On May 12, registrant reported its net loss for the quarter ended March 31.
8-K 8-K 5/6/2016 5/4/2016
Abstract: Registrant reported that on May 4, its board of directors approved an amendment to the registrant’s amended and restated bylaws. The amended and restated bylaws were included by exhibit.

Displaying 1 to 20 (of 49 filings)
  • 1